Target Price | $24.00 |
Price | $2.20 |
Potential |
990.91%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a INVO Bioscience Inc price target 2026.
The average INVO Bioscience Inc target price is $24.00.
This is
990.91%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend INVO Bioscience Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the INVO Bioscience Inc stock has an average upside potential 2026 of
990.91%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 3.02 | 6.35 |
268.29% | 110.13% | |
Net Margin | -652.40% | -78.06% |
92.25% | 88.03% |
1 Analyst has issued a sales forecast INVO Bioscience Inc 2024 . The average INVO Bioscience Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast INVO Bioscience Inc 2024 . The average INVO Bioscience Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -61.57 | -15.48 |
71.45% | 74.86% | |
P/E | negative | |
EV/Sales | 2.11 |
1 Analysts have issued a INVO Bioscience Inc forecast for earnings per share. The average INVO Bioscience Inc EPS is
This results in the following potential growth metrics and future valuations:
INVO Bioscience Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
Maxim Group |
Locked
➜
Locked
|
Locked | Jan 23 2025 |
Analyst Rating | Date |
---|---|
Locked
Maxim Group:
Locked
➜
Locked
|
Jan 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.